BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6398345)

  • 1. Role of Dapsone in chemotherapy of leprosy--a comparison of responses to therapy in two cohorts in 1960s and 1970s.
    Reddy BN; Neelan PN
    Indian J Lepr; 1984; 56(4):912-8. PubMed ID: 6398345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of 922 bacteriologically positive leprosy cases.
    Koticha KK; Nair PR; Juwatkar PS
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):330-4. PubMed ID: 6890538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):161-72. PubMed ID: 1522358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary dapsone resistant leprosy in Nepal.
    Samuel NM; Samuel S; Loudon J; Adiga RB
    Indian J Lepr; 1984; 56(4):819-22. PubMed ID: 6398343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial clearance with WHO--recommended multidrug regimen for multibacillary leprosy.
    Kishore BN; Shetty JN
    Indian J Lepr; 1995; 67(3):301-8. PubMed ID: 8576609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.
    Balakrishnan S; Ramu G
    Lepr India; 1977 Jan; 49(1):59-64. PubMed ID: 330945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 10. Infectivity of secondary dapsone-resistant cases.
    Jesudasan K; Pannikar V; Christian M
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):418-21. PubMed ID: 3047282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug sensitivity of M. leprae isolated from leprosy patients administered DDS for long period of time.
    Murohashi T; Yoshida K
    Acta Leprol; 1978; (73):13-28. PubMed ID: 108909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation and relapse in bacterio-negative cases of leprosy under sulphone therapy: a 4 1/2 years follow-up.
    Neelan PN
    Lepr India; 1976 Oct; 48(4 Suppl):661-7. PubMed ID: 1026801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
    Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
    Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple relapses in borderline leprosy--a case report.
    Ramachandran A; Seshadri PS
    Indian J Lepr; 1986; 58(4):623-5. PubMed ID: 3553362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.